We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

AI Identifies Non-Smokers at High Risk for Lung Cancer from Single Chest X-Ray

By MedImaging International staff writers
Posted on 08 Dec 2023
Print article
Image: The AI tool can identify non-smokers who are at high risk for lung cancer using a single X-ray (Photo courtesy of 123RF)
Image: The AI tool can identify non-smokers who are at high risk for lung cancer using a single X-ray (Photo courtesy of 123RF)

Lung cancer is currently the leading cause of cancer mortality. Notably, 10-20% of lung cancer cases are diagnosed in individuals classified as "never-smokers" – those who have either never smoked or have smoked fewer than 100 cigarettes in their lifetime. The prevalence of lung cancer in never-smokers is increasing, and these cases are often more advanced at the time of discovery due to the lack of early detection methods typically used for smokers. Now, a new study has found that an artificial intelligence (AI) tool is capable of identifying non-smokers at high risk for lung cancer by analyzing routine chest X-ray images.

Conducted by the Massachusetts General Hospital (MGH, Boston, MA, USA), this study aimed to enhance the prediction of lung cancer risk in never-smokers. The research team employed a deep learning model, a sophisticated form of AI, to analyze chest X-ray images from the electronic medical record, searching for patterns indicative of disease. The deep learning model, named "CXR-Lung-Risk," was trained using 147,497 chest X-rays from 40,643 asymptomatic individuals, both smokers and never-smokers. This model was designed to assess lung-related mortality risk from a single chest X-ray.

The effectiveness of the model was then tested on a separate cohort of never-smokers who underwent routine outpatient chest X-rays between 2013 and 2014. The primary measure was the incidence of lung cancer within six years, identified via International Classification of Disease codes. The model categorized the risk scores into low, moderate, and high-risk groups based on predetermined risk thresholds. In the study group of 17,407 patients, averaging 63 years of age, the model classified 28% as high risk, and within this group, 2.9% later had a diagnosis of lung cancer. The high-risk group surpassed the 1.3% six-year risk threshold where lung cancer screening CT is recommended by the US National Comprehensive Cancer Network guidelines. After taking into account age, sex, race, previous lower respiratory tract infection, and prevalent chronic obstructive pulmonary disease, the high-risk group still had a 2.1 times greater risk of developing lung cancer than the low-risk group.

"This AI tool opens the door for opportunistic screening for never-smokers at high risk of lung cancer, using existing chest X-rays in the electronic medical record," said senior author Michael T. Lu, M.D., M.P.H., director of artificial intelligence and co-director of CIRC at MGH. "Since cigarette smoking rates are declining, approaches to detect lung cancer early in those who do not smoke are going to be increasingly important."

Related Links:

Gold Member
Solid State Kv/Dose Multi-Sensor
Under Table Shield
3 Section Double Pivot Under Table Shield
Portable Radiology System
DR Flat Panel Detector

Print article



view channel
Image: The VR visualization platform provides patients and surgeons with access to real-time 3D medical imaging (Photo courtesy of Avatar Medical)

VR Visualization Platform Creates 3D Patient Avatars from CT and MR Images in Real-Time

Surgeons and patients must currently rely on black and white medical images interpreted by radiologists. This limitation becomes more pronounced in complex surgeries, leading to issues such as patient... Read more


view channel
Image: Intravascular ultrasound provides a more accurate and specific picture of the coronary arteries (Photo courtesy of 123RF)

Intravascular Imaging Significantly Improves Outcomes in Cardiovascular Stenting Procedures

Individuals with coronary artery disease, which involves plaque accumulation in the arteries leading to symptoms like chest pain, shortness of breath, and heart attacks, often undergo a non-surgical procedure... Read more

Nuclear Medicine

view channel
Image: The PET imaging technique can noninvasively detect active inflammation before clinical symptoms arise (Photo courtesy of 123RF)

New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear

Rheumatoid arthritis, the most common form of inflammatory arthritis, affects 18 million people globally. It is a complex autoimmune disease marked by chronic inflammation, leading to cartilage and bone... Read more

General/Advanced Imaging

view channel
Image: Routine chest CT holds untapped potential for revealing patients at risk for cardiovascular disease (Photo courtesy of Johns Hopkins)

Routine Chest CT Exams Can Identify Patients at Risk for Cardiovascular Disease

Coronary artery disease (CAD) is the primary cause of death globally. Adults without symptoms but at risk can be screened using EKG-gated coronary artery calcium (CAC) CT scans, which are crucial in assessing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.